GPT and type 2 diabetes mellitus: Based on the chi-square/ Fischer’s exact test result, a statistically significant difference in COVID-19 disease severity was observed among the groups classified by the presence of cardiac disease, hypertension, type II diabetes mellitus and the laboratory biomarkers of NLR, platelet count, SGPT, SGOT, ALP, Na, K.